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ORIGINAL ARTICLE
A visual motor psychological test as a predictor to
treatment in nocturnal enuresis
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Background and Aims: The neurological control of bladder function and the ability to be dry at night
involves not only the acquisition of normal daytime control, but also the establishment of a circadian
rhythm in vasopressin release and the ability to arouse to a full bladder during sleep. We postulated
that in some children there might be a delay in maturation of the normal neurological pathways
involved in establishment of nocturnal continence and examined this by using a specific neuropsycho-
logical test.
Methods: Children attending an established nocturnal enuresis clinic were examined using the Rey–
Osterrieth test to assess the presence or absence of boundary errors in both copy and memory repro-
ductions. The results of the test were scored independently and blind to the response to treatment with
the vasopressin analogue DDAVP.
Results: A significant association was found between boundary type errors and response to DDAVP,
with non-responders making significantly more errors. No child with three or more errors responded to
DDAVP. Using this test, the ability to predict response to treatment was 70%.
Conclusions: It is postulated that the Rey–Osterrieth test, through the presence or absence of bound-
ary errors, reflects a delay in maturation and/or a disorganisation of the retinal-hypothalamic-cortical
pathways in the brain. The association previously described with growth hormone neurosecretory dys-
function syndrome would be compatible with this.
The mechanisms underlying the normal postnatal develop-ment of bladder control are not fully understood. It is clear,however, that the central nervous systemmust play a role in
converting the process from a reflex action into one that is
under voluntary control. A delay in this process has been postu-
lated as a cause of nocturnal enuresis in some children.1
Butler and Holland have summarised factors involved in the
aetiology of nocturnal enuresis into a three systems model
suggesting that the treatment of nocturnal enuresis requires
an understanding of these three components: a failure to pro-
duce vasopressin at night, bladder instability, and a failure to
wake to a full bladder.2 Each component of the three systems
may be influenced by endogenous or exogenous factors.
Therefore to obtain night time continence it not only requires
an intact neurological pathway as for daytime continence, but
the ability to develop a circadian release of vasopressin at
night and to wake from sleep if urine production exceeds
bladder capacity. The aetiological factors described above sug-
gest that a disorder in the neurological pathway at any point in
the visual-hypothalamic-pituitary axis and the locus coerulus
and bladder could result in enuresis.
The Rey–Osterrieth figure test (fig 1) is a neuropsychologi-
cal test devised in 1941 by Andre Rey and used in children by
Osterrieth in 1946. It has been widely used in the
neuropsychological and clinical psychological assessment of
children, and allows assessment of a variety of cognitive proc-
esses, including planning and organisational skills and
problem solving strategies, as well as perceptual, motor, and
memory functions. Waber and Holmes studied children’s
reproduction of the Rey–Osterrieth figure and determined the
developmental change children make in both copying and
recalling the figure.3 Andronikoff-Sanglade et al, using this
test, noted that specific, previously unrecognised boundary
type errors, were highly concordant (p < 0.0005) with the
growth hormone neurosecretory dysfunction syndrome.4
These are children who have normal growth hormone
response to specific stimulation tests but have low endogenous
nocturnal secretion.5 These boundary type errors described by
Andronikoff-Sanglade et al are not featured as part of the nor-
mal developmental changes and were a coincidental finding
when studying children with short stature. These errors were
unrelated to developmental or intelligence quotient.
We postulated that some children with nocturnal enuresis
might have similar findings with a neuronal developmental
abnormality affecting the visual-hypothalamic-pituitary axis.
The study therefore examined children with nocturnal
enuresis comparing those responsive and unresponsive to
treatment with the vasopressin analogue DDAVP.
METHODS
Children were recruited from an established nocturnal
enuresis clinic run at Leeds General Infirmary. They were
entered into the study if they fulfilled the following criteria: 7
Figure 1 The Rey–Osterrieth figure.
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years or over with primary monosymptomatic nocturnal enu-
resis and on average greater than four wet nights per week; in
fulltime education with no statement of educational need; no
known neurological or urological problem; and gave informed
consent. Two groups of children were entered: a retrospective
group, who were already on treatment, and a prospective
group, who were recruited during the study.
The Rey–Osterrieth figure test was administered in two
parts. Firstly the child was asked to copy the figure on a blank
piece of paper the same size as the model. As each section was
finished, the child was handed a different coloured pencil and
a note made of the colour sequence. There is no time limit for
completion. Once finished both the figure and the child’s
reproduction were removed from sight and approximately
three minutes spent talking about unrelated issues. The child
was then asked to draw the figure from memory onto a same
size blank sheet of paper using a pencil with no colour change.
The child is not forewarned of the task.
The figures were scored on the basis of the boundary type
errors first described by Andronikoff-Sanglade and qualitative
analysis of the Rey–Osterrieth figure was performed using
three cut off points (table 1). One author (SB) completed the
scoring after each child was allocated a random number. The
author was, consequently, blind to which child was being
Table 1 Description of boundary type errors in the Rey–Osterrieth figure with cut off
points used in the study
Item Item number Description
Main rectangular structure 1 Absent (several disconnected elements scattered around)
2 Open (one or more sides missing)
3 Crossed by an incongruous line
(discounting slight crossings at angles and junctions)
External details 4 Detached from main structure
5 Included in main structure
Internal details 6 Entirely disconnected from adjacent elements
7 Cross main structure boundary
8 Placed on top of another main structural element or
incongruously crossed by a line
Cut off point 1. Rey–Osterrieth figure contains one or more boundary errors in either copy or memory
reproduction.
Cut off point 2. Rey–Osterrieth figure contains one or more errors in the copy reproduction only.
Cut off point 3. Rey–Osterrieth figure contains three or more boundary errors in either copy or memory
reproductions.
Table 2 Details of each group
Retrospective Prospective Difference
Number recruited 15 19 –
Mean age (SD) 13.3 (1.71) 9.3 (2.10) t=5.97
p<0.0001
Male/female 12/3 14/5 Fisher exact
p=0.99
Response to DDAVP 8 7 χ2=0.38
p=0.54
Number committing error (copy or memory) 8 15 Fisher exact
p=0.15
Mean height % (SD) 57.7 (31.47) 56.6 (31.08) t=0.10
p=0.98
Table 3 Number of children making errors
Errors
0 1 2 3+ Any
Children making errors in either copy or memory reproduction
Responds to DDAVP 8 1 6 0 7
No response to DDAVP 3 3 2 11 16
(for comparison of 0 errors with 1+ errors, Fisher exact p=0.0301;
for comparison of 0–2 errors with 3+ errors, Fisher exact p=0.0005)
Children making errors in copy reproduction only
Responds to DDAVP 13 2 0 0 2
No response to DDAVP 5 7 4 3 14
(for comparison of 0 errors with 1+ errors, χ2=9.95, p=0.002)
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scored and did not know their response to DDAVP. Every fifth
test was remarked to establish the level of intrapersonal vari-
ation in marking.
One author (PH), who was blind to the results of the
psychological test, determined the child’s response to treat-
ment with DDAVP. Success was defined as more than 10 out of
14 nights on average dry, representing at least an 80%
improvement in dry nights.
RESULTS
A total of 34 children were recruited to the study, 15 in the
retrospective group and 19 in the prospective group. Table 2
gives details of each group. The groups differed only in terms
of age, although there was no significant difference in terms of
boundary type errors (Mann–Whitney test, z = −1.21,
p = 0.226). The two groups were consequently combined for
analysis. Although there was a significant difference between
ages in the responders (12.3 years) and non-responders (10.0
years) (Mann–Whitney z = −2.43, p = 0.015), there was no
significant association between age and overall number of
boundary errors (Spearman r = –0.264, p = 0.13). There was
no significant difference in age between those who fell above
or below the three cut off points, outlined in table 1. Mean
ages below and above “cut off point 1” were 11.6 and 10.8
years (Mann–Whitney z = −0.78, p = 0.44), “point 2” 11.7
and 10.3 years (z = −1.43, p = 0.15), and “point 3” 11.7 and
9.7 years (z = −1.93, p = 0.054).
A significant association was found between boundary type
errors and response to DDAVP, with non-responders making
significantly more errors (Mann–Whitney test, z = −2.99,
p = 0.003). In both copy and memory task, 11 children (32%
of 34) studied made no errors at all, four (12%) made one
error, eight (24%) made two errors, and 11 (32%) made three
ormore errors. In copy reproduction, only 18 (53% of 34)made
no error, nine (26%) made one error, four (12%) two errors,
and three (9%) made three or more errors. Highly significant
differences were found between responders and non-
responders using these cut off points (table 3). No child with
three or more errors responded to DDAVP. Table 4 shows the
ability to predict response to treatment.
Figures 2 and 3 show the reproductions of the Rey–
Osterrieth figure completed by two 12 year old boys. In fig 2
the child made no errors and responded to DDAVP. In fig 3A
and B the child made errors in both the copy and memory
reproductions and did not respond to DDAVP.
DISCUSSION
Andronikof-Sanglade made a chance observation during rou-
tine assessment of children with growth hormone neurosecre-
tory dysfunction syndrome, noting specific boundary type
errors on the Rey–Osterrieth test. This test is independent of
development (age) or intelligence and has been validated by
Andronikof-Sanglade. We postulated that this test may reflect
delayed development in the neuronal pathways related to the
midbrain and hypothalamic-pituitary axis, and therefore may
be abnormal in children with primary enuresis. In children
with nocturnal enuresis we showed that those children unre-
sponsive to DDAVP had a highly significant increase in
boundary type errors, independent of growth.
Jarvelin has reported that children with poor linear growth
were more likely to have nocturnal enuresis. Devitt et al, using
a generalised linear model analysis, showed that the shorter
Table 4 Ability to predict response to treatment
Cut off points
1 2 3
Sensitivity (%) 53 87 100
Specificity (%) 84 74 58
Positive predictive value (%) 73 72 65
Negative predictive value (%) 70 88 100
Likelihood ratio for positive result 3.31 3.35 2.38
Pre-test probability (%) 41 41 41
Post-test probability (%) 70 70 62
Figure 2 Copy reproduction of the Rey–Osterrieth figure by a 12
year old boy who made no boundary type errors and responded to
DDAVP.
Figure 3 (A) Copy reproductions of the Rey–Osterrieth figure by a
12 year old boy who made boundary type errors and did not
respond to DDAVP. (B) Memory reproduction of the Rey–Osterrieth
figure with boundary type errors. The arrows indicate the type of
boundary error (see table 2).
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the child the less likely they were to respond to DDAVP.6 7
Stimulation of growth and the development of nocturnal con-
tinence both depend on the night time release of growth hor-
mone and vasopressin respectively. The establishment of these
circadian rhythms depends on the maturation of neurological
pathways, including the retinohypothalamic projection direct
to the suprachiasmatic nucleus, the body’s internal clock. The
hypothalamus acts as the principal control on the production
of both growth hormone via the anterior pituitary, and vaso-
pressin via the posterior pituitary. Vasopressin is synthesised
in the suprachiasmatic nucleus and is transferred, attached to
its carrier protein neurophysin, down the magnocellular neu-
rones to be stored in vesicles within the posterior pituitary. At
term only about 13% of the adult number of neurones are
present; this number increases rapidly over the first few
months after birth and coincides with the establishment of
overt diurnal rhythms.8 Jarvelin and Devitt et al have also
shown an association between nocturnal enuresis and low
birth weight, again suggesting the possibility of maturational
delay.
Andronikoff-Sanglade postulated that these specific errors
were identifying a corticohypothalamic disturbance that
resulted in poor growth hormone production at night. Height
was therefore included as a confounding variable to ensure
that this study was not simply including children with this
syndrome. The fact that no such association was found
suggests that this was not the case. Interestingly, in this study
the presence of boundary type errors was muchmore sensitive
to the child’s current ability to respond, rather than their abil-
ity in the past, suggesting an ability of the system to mature
with time. Linking this study to that of Andronikoff-Sanglade
suggests a maturational delay in the retinal-hypothalamic
pituitary axis that can potentially be detected using the Rey–
Osterrieth test. We postulate that pre- and postnatal factors at
a crucial period of neuronal development affect the matura-
tion of neurones in the midbrain and hypothalamus,
manifesting as a delay in growth and attainment of nocturnal
continence. An understanding of the factors, whether
environmental or genetic, which contribute to this may result
in a better understanding of the management of nocturnal
enuresis. If these studies are replicated, they are potentially
important in defining a treatment programme for the older
child with enuresis, although the results should be viewed in
context of an increasing understanding of the pathophysiol-
ogy of nocturnal enuresis.
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